Americans are using more prescription drugs than ever. Consequently, they’re coping with more side effects, drug interactions, and costs, especially if they’re using multiple medications. Kaiser Permanente Washington Health Research Institute (KPWHRI) scientists are on the forefront of answering questions about these concerns. We’re studying the beneficial and harmful effects of medications in real-world settings, and innovating better ways to manage and monitor drug use.
The institute contributes to national initiatives to monitor medication safety as well as providing information to help doctors and patients weigh the risks and benefits of various prescription drugs.
Funders of KPWHRI medication use and patient safety research include the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the National Institutes of Health, the Patient-Centered Outcomes Research Institute, and other sources. A few projects include:
LaCroix AZ, Newton KM, Buist DSM, Keenan NL, Anderson LA. What factors account for differences in HRT prescribing by healthcare providers in a health maintenance organization? The EnPower Provider Survey. Menopause. 1997;4:262.
Anderson LA, Caplan LS, Buist DSM, Newton KM, Curry S, LaCroix AZ. Counseling about HRT: perceived barriers and recommendations among primary care providers. Menopause. 1997;4:263.
Newton KM, Anderson LA, LaCroix AZ, Buist DSM, Keenan NL. Healthcare provider characteristics and encouragement to use HRT: the EnPower provider survey. Menopause. 1997;4:263.
Heath HW, Allen JK. Acute dystonia following standard doses of a cold medicine containing phenylpropanolamine. Clin Pediatr (Phila). 1997;36(1):57-8. PubMed
Furberg CD, Psaty BM. Should calcium antagonists be first-line agents in the treatment of cardiovascular disease? The public health perspective. Cardiovasc Drugs Ther. 1996;10(4):463-6. PubMed
![]() Sascha Dublin, MD, PhDSenior Investigator |
![]() Jessica Chubak, PhDSenior Investigator |
![]() Andrea J. Cook, PhDSenior Biostatistics Investigator |
![]() Rita Mangione-Smith, MD, MPHExecutive Director and Senior Investigator, KPWHRI; Vice President for Research and Health Care Innovation, Kaiser Permanente Washington |
![]() Jennifer C. Nelson, PhDDirector, Biostatistics; Senior Investigator |
![]() David E. Arterburn, MD, MPHSenior Investigator |
![]() Susan M. Shortreed, PhDSenior Biostatistics Investigator |
![]() Lisa A. Jackson, MD, MPHSenior Investigator |
![]() Karen Wernli, PhDSenior Investigator |
![]() Onchee Yu, MSPrincipal Collaborative Biostatistician |
![]() Rod L. Walker, MSPrincipal Collaborative Biostatistician |
![]() Robert D. Wellman, MSPrincipal Collaborative Biostatistician |
![]() Gaia Pocobelli, PhDSenior Collaborative Scientist |
![]() Laura Harrington, PhD, MPHAssistant Investigator |
![]() Jennifer F. Bobb, PhDAssociate Biostatistics Investigator |
![]() Weiwei Zhu, MSSenior Collaborative Biostatistician |
![]() Paige D. Wartko, PhD, MPHSenior Collaborative Scientist |
![]() Maricela Cruz, PhDAssistant Biostatistics Investigator |
![]() Brian D. Williamson, PhDAssistant Biostatistics Investigator |
![]() Noorie Hyun, PhDAssociate Biostatistics Investigator |
![]() Laurel Hansell, MA, MPHCollaborative Scientist |
![]() Jess Mogk, MPHCollaborative Scientist |
![]() Annie Piccorelli, PhDSenior Collaborative Biostatistician |
Susan Heckbert, MD, PhD
University of Washington (UW) Department of Epidemiology; UW Cardiovascular Health Research Unit
David Siscovick, MD, MPH
UW Department of Medicine; UW Department of Epidemiology; UW Cardiovascular Health Research Unit
Leslie Spangler, PhD
Amgen